Abstract
Mortality associated with AIDS has declined after the introduction of highly active antiretroviral therapy (HAART) with fewer patients progressing to severe infections. This has affected the incidence and management of HIV complications to a great extent. The natural history, incidence, management and sequelae of a wide range of HIV-associated retinopathies, especially cytomegalovirus retinitis, have also drastically changed. The reduction in the incidence of ocular opportunistic infections due to HAART has been accompanied by a rise in the number of new HAART-associated syndromes such as immune recovery uveitis. Immune recovery uveitis is a HAART-dependent inflammatory response that may occur in patients with regressed cytomegalovirus retinitis and elevated CD4 count and has emerged as an important cause of ocular and visual morbidity.
Financial & competing interests disclosure
QD Nguyen serves on the Scientific Advisory Board for Bausch and Lomb. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.